WF
LH icon

Welch & Forbes’s Labcorp LH Stock Holding History

Welch & Forbes’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,630
Closed -$374K – 380
2024
Q4 		$374K Buy
1,630
+110
+7% +$25.2K ﹤0.01% 309
2024
Q3 		$340K Sell
1,520
-700
-32% -$154K ﹤0.01% 325
2024
Q2 		$443K Hold
2,220
– – 0.01% 298
2024
Q1 		$485K Sell
2,220
-393
-15% -$86.6K 0.01% 292
2023
Q4 		$594K Sell
2,613
-139
-5% -$29.2K 0.01% 265
2023
Q3 		$553K Sell
2,752
-439
-14% -$92.6K 0.01% 267
2023
Q2 		$661K Sell
3,191
-25
-0.8% -$4.85K 0.01% 259
2023
Q1 		$634K Sell
3,216
-110
-3% -$22.6K 0.01% 259
2022
Q4 		$673K Buy
3,326
+31
+0.9% +$6.06K 0.01% 253
2022
Q3 		$580K Buy
3,295
+72
+2% +$14.7K 0.01% 260
2022
Q2 		$649K Buy
3,223
+815
+34% +$174K 0.01% 259
2022
Q1 		$546K Buy
+2,408
New +$566K 0.01% 285

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Welch & Forbes's LH Position: Q1 2025 in Review

Welch & Forbes sold out of Labcorp (LH) in Q1 2025, closing a stake of 1,630 shares — an estimated $374K sold.

Welch & Forbes first reported a position in LH in Q1 2022 and held it in 12 quarters. The position peaked at $673K in Q4 2022. 976 funds tracked by Wall St. Rank hold LH as of Q1 2025.

  • Welch & Forbes reported no remaining Labcorp position as of Q1 2025 after selling out during the quarter.
  • Welch & Forbes sold 1,630 Labcorp shares in Q1 2025, an estimated $374K.
  • Welch & Forbes first reported a position in Labcorp in Q1 2022 and held it in 12 quarters.
  • Welch & Forbes's Labcorp position peaked at $673K in Q4 2022.
  • 976 funds tracked by Wall St. Rank held Labcorp as of Q1 2025.

Based on Welch & Forbes's 13F filing for Q1 2025, filed 2 May 2025.